Page last updated: 2024-08-24

cupric nitrilotriacetate and Cancer of Kidney

cupric nitrilotriacetate has been researched along with Cancer of Kidney in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamazaki, S; Hiai, H; Nakashima, Y; Nishiyama, Y; Okada, S; Okamoto, K; Tanaka, T; Toyokuni, S1
Athar, M; Giri, U; Iqbal, M1

Other Studies

2 other study(ies) available for cupric nitrilotriacetate and Cancer of Kidney

ArticleYear
Induction of renal cell carcinoma in male Wistar rats treated with cupric nitrilotriacetate.
    Laboratory investigation; a journal of technical methods and pathology, 1996, Volume: 75, Issue:2

    Topics: Animals; Carcinoma, Renal Cell; Copper; Kidney Neoplasms; Male; Nitrilotriacetic Acid; Organometallic Compounds; Rats; Rats, Wistar

1996
Copper-nitrilotriacetate (Cu-NTA) is a potent inducer of proliferative response both in liver and kidney but is a complete renal carcinogen.
    International journal of oncology, 1999, Volume: 14, Issue:4

    Topics: Animals; Carcinogens; Cell Division; Diethylnitrosamine; Kidney Neoplasms; Liver Neoplasms; Male; Mice; Nitrilotriacetic Acid; Organometallic Compounds

1999